Trial intelligence / Profile preview

Autologous peripheral blood mononuclear cell transplantation for refractory skin ulcers in connective tissue disease and vasculitis

jRCTb070190060Completed

Start
Apr 2017
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

Open-label, single-arm trial of autologous G-CSF mobilized peripheral blood mononuclear cells in Skin ulcer in connective tissue disease and vasculitis. Started Apr 2017; status: completed.

02

Drugs

autologous G-CSF mobilized peripheral blood mononuclear cells
03

Conditions

Skin ulcer in connective tissue diseasevasculitis

Beyond the preview

Go deeper on jRCTb070190060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTb070190060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call